Gianni Panagiotou

Prof. Dr. Gianni Panagiotou

Microbiome Dynamics · Leitung +49 3641 532-1759 gianni.panagiotou@leibniz-hki.de

Curriculum vitae

Forschungsschwerpunkte
  • Mikrobiom bei Gesundheit und Krankheit
  • Systembiologie von Infektionskrankheiten
  • Personalisierte Ernährung

Publikationen

Loos D*, Pereira da Costa Filho A*, Dutilh B E, Barber AE#, Panagiotou G# (2024) A global survey of host, aquatic, and soil microbiomes reveals shared abundance and genomic features between bacterial and fungal generalists. Cell Rep 43(4), 114046.
McIlroy SE#, Guibert I, Archana A, Chung WYH, Duffy JE, Gotama R, Hui J, Knowlton N, Leray M, Meyer C, Panagiotou G, Paulay G, Russell B, Thompson PD, Baker DM # (2024) Life goes on: Spatial heterogeneity promotes biodiversity in an urbanized coastal marine ecosystem. Glob Chang Biol 30(4), e17248.
Peng H, Schmiederer J, Chen X, Panagiotou G, Kries H# (2024) Controlling substrate- and stereospecificity of condensation domains in nonribosomal peptide synthetases. ACS Chem Bio 19(3), 599-606.
Senne de Oliveira Lino F*, Garg S*, Li SS, Misiakou MA, Kang K, Labate Vale da Costa B, Svend-Aage Beyer-Pedersen T, Guerra Giacon T, Basso TO, Panagiotou G, Sommer MOA# (2024) Strain dynamics of contaminating bacteria modulate the yield of ethanol biorefineries. Nat Commun 15(1), 5323.
Soll D*, Chu CF*, Sun S*, Lutz V, Arunkumar M, Gachechiladze M, Schäuble S, Alissa-Alkhalaf M, Nguyen T, Khalil MA, Garcia-Ribelles I, Mueller M, Buder K, Michalke B, Panagiotou G, Ziegler-Martin K, Benz P, Schatzlmaier P, Hiller K, Stockinger H, Luu M, Schober K, Moosmann C, Schamel WW, Huber M, Zielinski CE# (2024) Sodium chloride in the tumor microenvironment enhances T cell metabolic fitness and cytotoxicity. Nat Immunol 25(10), 1830-1844.
Sprague JL, Schille TB, Allert S, Trümper V, Lier A, Großmann P, Priest EL, Tsavou A, Panagiotou G, Naglik JR, Wilson D, Schäuble S, Kasper L*, Hube B*# (2024) Candida albicans translocation through the intestinal epithelial barrier is promoted by fungal zinc acquisition and limited by NFκBmediated barrier protection. PLOS Pathog 20(3), e1012031.
Wang Y*, Chen J*, Ni Y, Liu Y, Gao X, Tse MA, Panagiotou G#, Xu A# (2024) Exercise-changed gut mycobiome as a potential contributor to metabolic benefits in diabetes prevention: an integrative multi-omics study. Gut Microbes 16(1), 2416928.
Yuu EY, Bührer C, Eckmanns T, Fulde M, Herz M, Kurzai O, Lindstedt C, Panagiotou G, Piro VC, Radonic A, Renard BY, Reuss A, Leal Siliceo S, Thielemann N, Thürmer A, van Vorst K, Wieler LH, Haller S# (2024) The gut microbiome, resistome, and mycobiome in preterm newborn infants and mouse pups: lack of lasting effects by antimicrobial therapy or probiotic prophylaxis. Gut Pathog 16(1), 27.
Zhou Z*, Kleis L*, Depetris-Chauvin A*, Jaskulski S, Damerell V, Michels KB, Gigic B, Nöthlings U#, Panagiotou G# (2024) Beneficial microbiome and diet interplay in early-onset colorectal cancer. EMBO Mol Med 17(1), 9-30.
Brandt P*, Mirhakkak MH*, Wagner L, Driesch D, Möslinger A, Fänder P, Schäuble S, Panagiotou G, Vylkova S# (2023) High-throughput profiling of Candida auris isolates reveals clade-specific metabolic differences. Microbiol Spectr 11(3), e0049823. (Review)

Aktuelles